GKB Ophthalmics Ltd (NSE: GKB), ISIN INE265D01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GKB last traded at ₹57.00 (-0.37%), with a 52-week range of ₹45.25 to ₹91.70 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 51.13%, FIIs 1.79%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 23/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.